Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

George is a professor of genetics at Harvard Medical School and professor of health sciences and technology at Harvard and MIT. He is a prolific researcher studying genetic sequencing, genome editing, ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...

U.S. biotech firm Dyne Therapeutics develops treatments for rare neuromuscular diseases, including Duchenne muscular ...